235 related articles for article (PubMed ID: 25920494)
21. Utility of the F98 rat glioma model for photodynamic therapy.
Madsen SJ; Kharkhuu K; Hirschberg H
J Environ Pathol Toxicol Oncol; 2007; 26(2):149-55. PubMed ID: 17725541
[TBL] [Abstract][Full Text] [Related]
22. Proton magnetic resonance spectroscopy in the distinction of high-grade cerebral gliomas from single metastatic brain tumors.
Server A; Josefsen R; Kulle B; Maehlen J; Schellhorn T; Gadmar Ø; Kumar T; Haakonsen M; Langberg CW; Nakstad PH
Acta Radiol; 2010 Apr; 51(3):316-25. PubMed ID: 20092374
[TBL] [Abstract][Full Text] [Related]
23. Effectiveness of controlled release of a cyclophosphamide derivative with polymers against rat gliomas.
Judy KD; Olivi A; Buahin KG; Domb A; Epstein JI; Colvin OM; Brem H
J Neurosurg; 1995 Mar; 82(3):481-6. PubMed ID: 7861228
[TBL] [Abstract][Full Text] [Related]
24. MRI assessment of treatment delivery for interstitial photodynamic therapy of high-grade glioma in a preclinical model.
Leroy HA; Vermandel M; Leroux B; Duhamel A; Lejeune JP; Mordon S; Reyns N
Lasers Surg Med; 2018 Jul; 50(5):460-468. PubMed ID: 29023876
[TBL] [Abstract][Full Text] [Related]
25. Glioma morphology and tumor-induced vascular alterations revealed in seven rodent glioma models by in vivo magnetic resonance imaging and angiography.
Doblas S; He T; Saunders D; Pearson J; Hoyle J; Smith N; Lerner M; Towner RA
J Magn Reson Imaging; 2010 Aug; 32(2):267-75. PubMed ID: 20677250
[TBL] [Abstract][Full Text] [Related]
26. Convection-enhancement delivery of liposomal formulation of oxaliplatin shows less toxicity than oxaliplatin yet maintains a similar median survival time in F98 glioma-bearing rat model.
Shi M; Fortin D; Paquette B; Sanche L
Invest New Drugs; 2016 Jun; 34(3):269-76. PubMed ID: 26961906
[TBL] [Abstract][Full Text] [Related]
27. Multimodal MRI in the characterization of glial neoplasms: the combined role of single-voxel MR spectroscopy, diffusion imaging and echo-planar perfusion imaging.
Zonari P; Baraldi P; Crisi G
Neuroradiology; 2007 Oct; 49(10):795-803. PubMed ID: 17619871
[TBL] [Abstract][Full Text] [Related]
28. Comparison of 3 Tesla proton MR spectroscopy, MR perfusion and MR diffusion for distinguishing glioma recurrence from posttreatment effects.
Fink JR; Carr RB; Matsusue E; Iyer RS; Rockhill JK; Haynor DR; Maravilla KR
J Magn Reson Imaging; 2012 Jan; 35(1):56-63. PubMed ID: 22002882
[TBL] [Abstract][Full Text] [Related]
29. Combination of intracranial temozolomide with intracranial carmustine improves survival when compared with either treatment alone in a rodent glioma model.
Recinos VR; Tyler BM; Bekelis K; Sunshine SB; Vellimana A; Li KW; Brem H
Neurosurgery; 2010 Mar; 66(3):530-7; discussion 537. PubMed ID: 20173548
[TBL] [Abstract][Full Text] [Related]
30. Bioluminescence and MR Imaging of the Safety and Efficacy of Vascular Disruption in Gliomas.
Folaron M; Seshadri M
Mol Imaging Biol; 2016 Dec; 18(6):860-869. PubMed ID: 27160251
[TBL] [Abstract][Full Text] [Related]
31. Systemic use of argatroban reduces tumor mass, attenuates neurological deficits and prolongs survival time in rat glioma models.
Hua Y; Tang LL; Fewel ME; Keep RF; Schallert T; Muraszko KM; Hoff JT; Xi GH
Acta Neurochir Suppl; 2005; 95():403-6. PubMed ID: 16463890
[TBL] [Abstract][Full Text] [Related]
32. Novel antitumor effect of carboplatin delivered by intracerebral microinfusion in a rat malignant glioma model.
Tange Y; Miyazaki M; Iwata J; Aiko Y; Sakamoto S; Mori K
Neurol Med Chir (Tokyo); 2009 Dec; 49(12):572-9. PubMed ID: 20035131
[TBL] [Abstract][Full Text] [Related]
33. OKN-007 Alters Protein Expression Profiles in High-Grade Gliomas: Mass Spectral Analysis of Blood Sera.
Towner RA; Hocker J; Smith N; Saunders D; Battiste J; Hanas J
Brain Sci; 2022 Jan; 12(1):. PubMed ID: 35053843
[TBL] [Abstract][Full Text] [Related]
34. Multisection 1H magnetic resonance spectroscopic imaging assessment of glioma response to chemotherapy.
Balmaceda C; Critchell D; Mao X; Cheung K; Pannullo S; DeLaPaz RL; Shungu DC
J Neurooncol; 2006 Jan; 76(2):185-91. PubMed ID: 16151595
[TBL] [Abstract][Full Text] [Related]
35. MR image-guided delivery of cisplatin-loaded brain-penetrating nanoparticles to invasive glioma with focused ultrasound.
Timbie KF; Afzal U; Date A; Zhang C; Song J; Wilson Miller G; Suk JS; Hanes J; Price RJ
J Control Release; 2017 Oct; 263():120-131. PubMed ID: 28288892
[TBL] [Abstract][Full Text] [Related]
36. In the assessment of supratentorial glioma grade: the combined role of multivoxel proton MR spectroscopy and diffusion tensor imaging.
Zou QG; Xu HB; Liu F; Guo W; Kong XC; Wu Y
Clin Radiol; 2011 Oct; 66(10):953-60. PubMed ID: 21663899
[TBL] [Abstract][Full Text] [Related]
37. Noninvasive evaluation of cerebral glioma grade by using diffusion-weighted imaging-guided single-voxel proton magnetic resonance spectroscopy.
Liu ZL; Zhou Q; Zeng QS; Li CF; Zhang K
J Int Med Res; 2012; 40(1):76-84. PubMed ID: 22429347
[TBL] [Abstract][Full Text] [Related]
38. Magnetic resonance imaging determination of tumor grade and early response to temozolomide in a genetically engineered mouse model of glioma.
McConville P; Hambardzumyan D; Moody JB; Leopold WR; Kreger AR; Woolliscroft MJ; Rehemtulla A; Ross BD; Holland EC
Clin Cancer Res; 2007 May; 13(10):2897-904. PubMed ID: 17504989
[TBL] [Abstract][Full Text] [Related]
39. OKN-007 Increases temozolomide (TMZ) Sensitivity and Suppresses TMZ-Resistant Glioblastoma (GBM) Tumor Growth.
Towner RA; Smith N; Saunders D; Brown CA; Cai X; Ziegler J; Mallory S; Dozmorov MG; Coutinho De Souza P; Wiley G; Kim K; Kang S; Kong DS; Kim YT; Fung KM; Wren JD; Battiste J
Transl Oncol; 2019 Feb; 12(2):320-335. PubMed ID: 30468988
[TBL] [Abstract][Full Text] [Related]
40. Magnetic resonance imaging of ethyl-nitrosourea-induced rat gliomas: a model for experimental therapeutics of low-grade gliomas.
Kish PE; Blaivas M; Strawderman M; Muraszko KM; Ross DA; Ross BD; McMahon G
J Neurooncol; 2001 Jul; 53(3):243-57. PubMed ID: 11718257
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
